Jentashapir Journal of Health Research

Published by: Kowsar

HFE Mutations C282Y and H63D in Iranian Population With Type 2 Diabetes

Neda Golchin 1 , Hajie Bibi Shahbazian 2 , Heshmatollah Shahbazian 2 , Alireza Zare Bidoki 3 and Javad Mohammadi Asl 2 , *
Authors Information
1 Cancer Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jentashapir Journal of Health Research: April 2015, 6 (2); e24659
  • Published Online: April 25, 2015
  • Article Type: Research Article
  • Received: October 17, 2014
  • Revised: January 25, 2015
  • Accepted: February 11, 2015
  • DOI: 10.5812/jjhr.6(2)2015.24659

To Cite: Golchin N, Shahbazian H B, Shahbazian H, Zare Bidoki A, Mohammadi Asl J. et al. HFE Mutations C282Y and H63D in Iranian Population With Type 2 Diabetes, Jundishapur J Helath Res. 2015 ;6(2):e24659. doi: 10.5812/jjhr.6(2)2015.24659.

Abstract
Copyright: Copyright © 0, Jentashapir Journal of Health Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Andrulionyte L, Zacharova J, Chiasson JL, Laakso M, Stop-Niddm Study Group . Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia. 2004; 47(12): 2176-84[DOI][PubMed]
  • 2. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013; 93(1): 137-88[DOI][PubMed]
  • 3. Franks PW. Gene x environment interactions in type 2 diabetes. Curr Diab Rep. 2011; 11(6): 552-61[DOI][PubMed]
  • 4. Chauhan G, Spurgeon CJ, Tabassum R, Bhaskar S, Kulkarni SR, Mahajan A, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians. Diabetes. 2010; 59(8): 2068-74[DOI][PubMed]
  • 5. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004; 291(6): 711-7[DOI][PubMed]
  • 6. Rajpathak SN, Wylie-Rosett J, Gunter MJ, Negassa A, Kabat GC, Rohan TE, et al. Biomarkers of body iron stores and risk of developing type 2 diabetes. Diabetes Obes Metab. 2009; 11(5): 472-9[PubMed]
  • 7. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia. 2007; 50(5): 949-56[DOI][PubMed]
  • 8. McCarthy MI. Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification. Hum Mol Genet. 2004; 13 Spec No 1-41[DOI][PubMed]
  • 9. Njajou OT, Houwing-Duistermaat JJ, Osborne RH, Vaessen N, Vergeer J, Heeringa J, et al. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Eur J Hum Genet. 2003; 11(3): 225-31[DOI][PubMed]
  • 10. Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes. 2002; 51(8): 2348-54[PubMed]
  • 11. Gomes KB, Carvalho MG, Coelho FF, Rodrigues IF, Soares AL, Guimaraes DA, et al. Lack of association of C282Y and H63D mutations in the hemochromatosis (HFE) gene with diabetes mellitus type 2 in a case-control study of women in Brazil. Genet Mol Res. 2009; 8(4): 1285-91[DOI][PubMed]
  • 12. Rasmussen ML, Folsom AR, Catellier DJ, Tsai MY, Garg U, Eckfeldt JH. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2001; 154(3): 739-46[PubMed]
  • 13. Hannuksela J, Leppilampi M, Peuhkurinen K, Karkkainen S, Saastamoinen E, Helio T, et al. Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2005; 7(1): 103-8[DOI][PubMed]
  • 14. Surber R, Sigusch HH, Kuehnert H, Figulla HR. Haemochromatosis (HFE) gene C282Y mutation and the risk of coronary artery disease and myocardial infarction: a study in 1279 patients undergoing coronary angiography. J Med Genet. 2003; 40(5)[PubMed]
  • 15. Zorc M, Hruskovicova H, Petrovic MG, Milcic M, Peterlin B, Petrovic D. Haemochromatosis-causing mutations C282Y and H63D are not risk factors for coronary artery disease in Caucasians with type 2 diabetes. Folia Biol (Praha). 2004; 50(2): 69-70[PubMed]
  • 16. Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C, et al. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology. 2002; 36(1): 142-9[DOI][PubMed]
  • 17. Bugianesi E, Manzini P, D'Antico S, Vanni E, Longo F, Leone N, et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology. 2004; 39(1): 179-87[DOI][PubMed]
  • 18. Shaheen NJ, Silverman LM, Keku T, Lawrence LB, Rohlfs EM, Martin CF, et al. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst. 2003; 95(2): 154-9[PubMed]
  • 19. Hruskovicova H, Milanez T, Kobal J, Potisk KP, Petrovic D, Peterlin B. Hemochromatosis-causing mutations C282Y and H63D are not risk factors for atherothrombotic cerebral infarction. Med Sci Monit. 2005; 11(7)-52[PubMed]
  • 20. Zhang A, Park SK, Wright RO, Weisskopf MG, Mukherjee B, Nie H, et al. HFE H63D polymorphism as a modifier of the effect of cumulative lead exposure on pulse pressure: the Normative Aging Study. Environ Health Perspect. 2010; 118(9): 1261-6[DOI][PubMed]
  • 21. Pankow JS, Boerwinkle E, Adams PC, Guallar E, Leiendecker-Foster C, Rogowski J, et al. HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study. Transl Res. 2008; 152(1): 3-10[DOI][PubMed]
  • 22. Valenti L, Dongiovanni P, Fracanzani AL, Santorelli G, Fatta E, Bertelli C, et al. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Dig Liver Dis. 2003; 35(3): 172-8[PubMed]
  • 23. Cauza E, Hanusch-Enserer U, Bischof M, Spak M, Kostner K, Tammaa A, et al. Increased C282Y heterozygosity in gestational diabetes. Fetal Diagn Ther. 2005; 20(5): 349-54[DOI][PubMed]
  • 24. Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, Larsen LE, Appleyard M, Frandsen M, et al. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet. 2001; 358(9291): 1405-9[DOI][PubMed]
  • 25. Rong Y, Bao W, Rong S, Fang M, Wang D, Yao P, et al. Hemochromatosis gene (HFE) polymorphisms and risk of type 2 diabetes mellitus: a meta-analysis. Am J Epidemiol. 2012; 176(6): 461-72[DOI][PubMed]
  • 26. Sampson MJ, Williams T, Heyburn PJ, Greenwood RH, Temple RC, Wimperis JZ, et al. Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes. J Lab Clin Med. 2000; 135(2): 170-3[DOI][PubMed]
  • 27. Qi L, Meigs J, Manson JE, Ma J, Hunter D, Rifai N, et al. HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women. Diabetes. 2005; 54(12): 3567-72[PubMed]
  • 28. Acton RT, Barton JC, Bell DS, Go RC, Roseman JM. HFE mutations in African-American women with non-insulin-dependent diabetes mellitus. Ethn Dis. 2001; 11(4): 578-84[PubMed]
  • 29. Kankova K, Jansen EH, Marova I, Stejskalova A, Pacal L, Muzik J, et al. Relations among serum ferritin, C282Y and H63D mutations in the HFE gene and type 2 diabetes mellitus in the Czech population. Exp Clin Endocrinol Diabetes. 2002; 110(5): 223-9[DOI][PubMed]
  • 30. Habeos IG, Psyrogiannis A, Kyriazopoulou V, Psilopanagiotou A, Papavassiliou AG, Vagenakis AG. The role of Hemochromatosis C282Y and H63D mutations in the development of type 2 diabetes mellitus in Greece. Hormones (Athens). 2003; 2(1): 55-60[PubMed]
  • 31. Malecki MT, Klupa T, Walus M, Czogala W, Greenlaw P, Sieradzki J. A search for association between hereditary hemochromatosis HFE gene mutations and type 2 diabetes mellitus in a Polish population. Med Sci Monit. 2003; 9(2)-5[PubMed]
  • 32. Sharifi F, Esmaeilzadeh A, Zali M. Hemochromatosis gene (HFE) mutations in patients with type 2 diabetes and their control group in an Iranian population. Saudi Med J. 2008; 29(6): 808-12[PubMed]
  • 33. Moczulski DK, Grzeszczak W, Gawlik B. Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy. Diabetes Care. 2001; 24(7): 1187-91[PubMed]
  • 34. Salonen JT, Tuomainen TP, Kontula K. Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study. BMJ. 2000; 320(7251): 1706-7[PubMed]
  • 35. Davis TM, Beilby J, Davis WA, Olynyk JK, Jeffrey GP, Rossi E, et al. Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2008; 31(9): 1795-801[DOI][PubMed]
  • 36. Oliva R, Novials A, Sanchez M, Villa M, Ingelmo M, Recasens M, et al. The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2. Endocrine. 2004; 24(2): 111-4[PubMed]
  • 37. Peterlin B, Globocnik Petrovic M, Makuc J, Hawlina M, Petrovic D. A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes. J Hum Genet. 2003; 48(12): 646-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader